Using abatacept to treat lung disease in patients with common variable immunodeficiency.
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
This study is looking at how well a medication called abatacept can help improve lung health in people with common variable immunodeficiency who have a specific lung condition, and it involves trying the drug for six months to see how it works.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10893921 on NIH RePORTER |
What this research studies
This research investigates the use of abatacept, a biologic drug, to treat granulomatous-lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). The study will involve a double-blind trial where participants will receive either abatacept or a placebo for six months, followed by an open-label phase where all participants will receive abatacept for an additional six months. The goal is to evaluate the effectiveness and safety of abatacept in improving lung function and overall health in these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with common variable immunodeficiency who are experiencing interstitial lung disease.
Not a fit: Patients without a diagnosis of common variable immunodeficiency or those not experiencing lung disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new effective treatment option for patients suffering from GLILD associated with CVID.
How similar studies have performed: Previous small-scale studies have shown promising results for abatacept in treating GLILD, indicating potential for success in this larger trial.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Jordan, Michael — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Jordan, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.